In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2019-10-07
NEOGNeogen CorpHerbert James LDirS - Sale+OE$63.71-25,334206,970-11%-$1,614,011
D
2019-10-02
NEOGNeogen CorpHerbert James LDirS - Sale+OE$63.64-25,333206,970-11%-$1,612,119
M
2019-10-02
IMMUImmunomedics IncAvoro Capital Advisors LLCSee Remarks, 10%P - Purchase$13.52+1,500,00044,513,516+3%+$20,280,000
2019-10-03
IMMUImmunomedics IncBall BryanChief Quality OfficerP - Purchase$14.18+5,00010,000+100%+$70,897
2019-10-01
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale$16.21-30,000294,538-9%-$486,402
2019-10-01
NEOGNeogen CorpHerbert James LDirS - Sale$67.17-20,000206,970-9%-$1,343,370
2019-09-26
VNRXVolitionrx LtdEight Corp Ltd10%S - Sale$6.03-46,23811,995,3320%-$278,792
D
2019-09-23
QDELQuidel Corp /de/Steward Randall JCFOS - Sale+OE$62.60-29,32819,459-60%-$1,836,041
M
2019-09-23
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale$16.59-100,000324,538-24%-$1,659,462
2019-09-20
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$25.81-15,590582,294-3%-$402,448
2019-09-17
OCXOncocyte CorpArno AndrewDirP - Purchase$2.16+50,000102,447+95%+$108,130
A
2019-09-13
QDELQuidel Corp /de/Gibson KarenSVP, IS, Bus. TransformationS - Sale$67.52-4,527759-86%-$305,640
2019-09-13
OCXOncocyte CorpKalajian Tony TSVP-Chief Accounting OfficerP - Purchase$1.98+10,00010,000New+$19,800
2019-09-12
LNTHLantheus Holdings, Inc.Duffy Michael PSVP, GCS - Sale$23.74-7,500131,390-5%-$178,028
DEM
2019-09-11
QDELQuidel Corp /de/Gibson KarenSVP, IS, Bus. TransformationS - Sale+OE$55.74-18,881759-96%-$1,052,395
D
2019-09-11
QDELQuidel Corp /de/Buechler Kenneth FDirS - Sale+OE$68.86-4,00050,433-7%-$275,421
D
2019-09-11
QDELQuidel Corp /de/Borkar Ratan SSVP, Intl Comm OperationsS - Sale+OE$70.00-5,57516,257-26%-$390,250
2019-09-11
OCXOncocyte CorpBroadwood Partners, L.P.10%P - Purchase$1.66+2,000,00022,199,679+10%+$3,320,000
D
2019-09-10
QDELQuidel Corp /de/Abney Michael Donald Jr.SVP - DistributionS - Sale+OE$65.00-8,7985,790-60%-$571,870
2019-09-12
OCXOncocyte CorpLevine Mitchell SCFOP - Purchase$2.01+10,00010,000New+$20,060
2019-09-04
LNTHLantheus Holdings, Inc.Duffy Michael PSVP, GCS - Sale$20.60-5,604138,890-4%-$115,465
2019-09-03
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$21.21-25,538597,884-4%-$541,679
DM
2019-08-28
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$62.18-71,708301,442-19%-$4,458,829
2019-08-27
VNRXVolitionrx LtdFaulkes Martin CharlesDirP - Purchase$3.75+10,0001,917,284+1%+$37,500
2019-08-20
NEOGNeogen CorpHerbert James LDirS - Sale$71.67-15,000494,272-3%-$1,075,109
D
2019-08-19
QTNTQuotient LtdBoyd RolandSee RemarksS - Sale+OE$10.95-21,10070,508-23%-$231,045
2019-08-14
IDXXIdexx Laboratories Inc /deHenderson Rebecca MDirS - Sale$271.17-4,00014,696-21%-$1,084,686
2019-08-16
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale$13.86-10,000424,538-2%-$138,647
2019-08-15
VNRXVolitionrx LtdFaulkes Martin CharlesDirP - Purchase$3.94+50,0001,907,284+3%+$197,000
2019-08-09
IDXXIdexx Laboratories Inc /deTwigge GiovaniCORPORATE VPS - Sale$274.44-2,30010,315-18%-$631,212
D
2019-08-08
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOBS - Sale+OE$272.75-10,0001,163,942-1%-$2,727,486
2019-08-06
IDXXIdexx Laboratories Inc /deKingsley Lawrence DDirP - Purchase$266.41+3757,778+5%+$99,904
D
2019-08-05
IDXXIdexx Laboratories Inc /deVandebroek Sophie V.DirS - Sale+OE$263.86-9,0449,178-50%-$2,386,336
D
2019-08-05
IDXXIdexx Laboratories Inc /deMazelsky JayInterim Pres, CEOS - Sale+OE$258.40-10,00023,270-30%-$2,584,044
D
2019-08-05
IDXXIdexx Laboratories Inc /deLane MichaelCorporate VPS - Sale+OE$264.10-17,9612,017-90%-$4,743,449
DM
2019-08-05
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOBS - Sale+OE$262.26-20,0001,163,942-2%-$5,245,139
D
2019-08-05
NEOGNeogen CorpAdent John EdwardPres, CEOS - Sale+OE$69.03-31,48912,813-71%-$2,173,604
A
2019-08-01
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale$12.90-3,0000-100%-$38,703
2019-08-01
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale$19.90-3,0000-100%-$59,703
2019-08-01
NEOGNeogen CorpParnell Jack CDirS - Sale$70.00-4395,000-8%-$30,730
D
2019-08-01
MYGNMyriad Genetics IncCapone Mark ChristopherPres, C.E.O.S - Sale+OE$44.00-137,000440,833-24%-$6,028,000
D
2019-08-01
MYGNMyriad Genetics IncKing Gary A.EVP International OpsS - Sale+OE$43.49-60,000134,871-31%-$2,609,329
2019-08-01
MYGNMyriad Genetics IncTobin BernardPres Crescendo BioScienceS - Sale$40.00-11,712146,040-7%-$468,480
2019-08-01
MYGNMyriad Genetics IncRiggsbee Richard BryanCFOS - Sale$41.50-25,000120,566-17%-$1,037,575
D
2019-07-29
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$57.78-21,789301,442-7%-$1,258,968
2019-07-29
NEOGNeogen CorpHerbert James LDirS - Sale$70.30-10,499301,874-3%-$738,097
D
2019-07-26
NEOGNeogen CorpReed Thomas HDirS - Sale+OE$69.77-8,00013,373-37%-$558,160
2019-07-26
NEOGNeogen CorpParnell Jack CDirS - Sale$69.59-5,0005,439-48%-$347,964
2019-07-26
NEOGNeogen CorpHerbert James LDirS - Sale$70.04-30,000506,454-6%-$2,101,305
D
2019-07-25
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$69.04-15,00013,470-53%-$1,035,527
M
2019-07-22
NEOGNeogen CorpHerbert James LDirS - Sale$64.92-27,771536,454-5%-$1,802,943
2019-07-19
NEOGNeogen CorpHerbert James LDirS - Sale$65.00-1,000564,2250%-$65,000
2019-07-18
NEOGNeogen CorpHerbert James LDirS - Sale$65.03-56,229565,225-9%-$3,656,673
M
2019-07-15
NEOGNeogen CorpHerbert James LDirS - Sale$63.97-10,000621,484-2%-$639,668
2019-07-10
LNTHLantheus Holdings, Inc.Duffy Michael PSVP, GCS - Sale$28.14-8,819144,494-6%-$248,167
2019-07-10
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$28.07-4,91827,549-15%-$138,048
2019-07-10
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.73+7,0003,510,5500%+$12,104
2019-07-08
NEOGNeogen CorpHerbert James LDirS - Sale$60.70-5,000631,484-1%-$303,510
D
2019-07-08
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale+OE$28.17-35,58668,483-34%-$1,002,615
2019-07-09
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.63+7,0003,503,5500%+$11,400
2019-07-05
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.45+9,0003,496,5500%+$13,049
2019-07-03
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$28.41-5,00032,467-13%-$142,050
2019-07-03
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.54+8,0003,487,5500%+$12,354
2019-07-02
OCXOncocyte CorpBroadwood Partners, L.P.10%P - Purchase$2.00+1,000,00018,199,679+6%+$2,000,000
D
2019-06-28
VRMLVermillion, Inc.Schuler Henri George10%P - Purchase$0.80+4,750,00013,764,495+53%+$3,800,000
2019-06-28
VRMLVermillion, Inc.Schuler Jack W10%P - Purchase$0.80+5,000,00022,378,242+29%+$4,000,000
2019-07-01
NEOGNeogen CorpHerbert James LDirS - Sale$61.52-5,000636,484-1%-$307,600
2019-07-01
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.37+9,0003,479,5500%+$12,305
2019-06-28
VRMLVermillion, Inc.Palmieri Valerie BarberPres, CEOP - Purchase$0.80+37,500215,563+21%+$30,000
M
2019-06-28
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$15.16+10,0003,470,5500%+$151,568
DM
2019-06-26
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$57.59-28,711301,442-9%-$1,653,481
M
2019-06-26
IMMUImmunomedics IncAvoro Capital Advisors LLCSee Remarks, 10%P - Purchase$13.55+1,000,00041,413,516+2%+$13,548,000
2019-06-26
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$27.67-5,00037,467-12%-$138,361
2019-06-27
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.56+9,0003,460,5500%+$14,023
A
2019-06-18
LNTHLantheus Holdings, Inc.Bolla John J.Chief Operations OfficerS - Sale$27.58-2,24136,405-6%-$61,807
2019-06-26
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.71+8,0003,451,5500%+$13,680
2019-06-25
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.73+9,0003,443,5500%+$15,533
2019-06-24
NEOGNeogen CorpHerbert James LDirS - Sale$61.41-5,000641,484-1%-$307,040
2019-06-20
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$27.89-14,340623,422-2%-$399,935
2019-06-18
NAVBNavidea Biopharmaceuticals, Inc.Scott John K Jr.10%P - Purchase$0.75+4,000,0005,123,217+356%+$3,000,000
2019-06-19
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$27.40-5,00042,467-11%-$137,015
2019-06-20
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.77+9,0003,434,5500%+$15,918
2019-06-20
IMMUImmunomedics IncBall BryanChief Quality OfficerP - Purchase$13.35+5,0005,000New+$66,750
D
2019-06-18
QDELQuidel Corp /de/Russell Edward KeithS.VP, N.A. Commercial OpsS - Sale+OE$57.16-13,0009,598-58%-$743,046
M
2019-06-18
LNTHLantheus Holdings, Inc.Bolla John J.Chief Operations OfficerS - Sale$27.56-1,74737,027-5%-$48,149
2019-06-19
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.69+8,0003,425,5500%+$13,529
2019-06-18
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.67+9,0003,417,5500%+$15,046
2019-06-17
NEOGNeogen CorpHerbert James LDirS - Sale$61.61-5,000646,484-1%-$308,060
2019-06-13
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.42+8,0003,408,5500%+$11,344
D
2019-06-13
QTNTQuotient LtdHallsworth FrederickDirP - Purchase$8.70+3,15077,548+4%+$27,405
2019-06-12
NEOGNeogen CorpHerbert James LDirS - Sale$60.65-20,000651,484-3%-$1,213,078
2019-06-12
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$25.27-5,00047,467-10%-$126,365
2019-06-11
ACHVAchieve Life Sciences, Inc.Armistice Capital, LLC10%S - Sale$2.86-47,1821,593,188-3%-$134,821
2019-06-11
ACHVAchieve Life Sciences, Inc.Armistice Capital, LLC10%S - Sale$3.16-264,9631,687,552-14%-$837,467
2019-06-11
ACHVAchieve Life Sciences, Inc.Armistice Capital, LLC10%P - Purchase$3.80+12,8131,687,552+1%+$48,689
2019-06-11
VNRXVolitionrx LtdFaulkes Martin CharlesDirP - Purchase$3.11+79,2691,857,284+4%+$246,134
2019-06-10
VNRXVolitionrx LtdFaulkes Martin CharlesDirP - Purchase$3.02+70,7311,778,015+4%+$213,608
2019-06-11
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.46+9,0003,400,5500%+$13,149
2019-06-10
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.54+8,0003,391,5500%+$12,288
2019-06-07
LNTHLantheus Holdings, Inc.Leno Sam RDirS - Sale$25.33-3,95049,580-7%-$100,059
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top